Use of dupilumab in pediatric atopic dermatitis: Access, dosing, and implications for managing severe atopic dermatitis

Pediatr Dermatol. 2019 Jan;36(1):172-176. doi: 10.1111/pde.13707.

¹ Saint Louis University, Saint Louis, Missouri.
² Cardinal Glennon Children's Hospital, Saint Louis, Missouri.
³ ApotheCom, Yardley, Pennsylvania.
⁴ Yale University School of Medicine, New Haven, Connecticut.
⁵ University of California, San Francisco School of Medicine, San Francisco, California.
⁶ Rady Children's Hospital, San Diego and University of California San Diego, School of Medicine, San Diego, California.
⁷ Dell Children's Medical Center of Central Texas and Dell Medical School, University of Texas at Austin, Austin, Texas.
⁸ Feinberg School of Medicine, Northwestern University and Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois.

No abstract available

Keywords: adverse effects; atopic dermatitis; biologic; dupilumab; pediatric drug use.

MeSH terms